Amgen Options Traders Betting On Stock Rising This Much By April Expiration

Within the next month, Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.

On CNBC’s "Options Action," Kelly Intelligence's Kevin Kelly said there were 1.84x more calls than puts on Amgen on Wednesday.

Don’t forget to check out our premarket coverage here

There was a buyer of 125 of the April 245-calls at an average price of $2.30 per contract, Kelly explained, adding that Amgen’s stock will gain at least 3% by April expiration.

Amgen recently announced plans to cut 450 jobs, or lower than 2% of its workforce. As of Dec. 31, 2022, the Thousand Oaks, California-based company had approximately 25,200 employees in over 50 countries.

Price Action: Amgen shares gained 1.1% to settle at $241.03 on Wednesday and added 0.3% in after-hours trading session.

Check This Out: Top 5 Risk Off Stocks That May Crash In March